Breast Cancer Risk for Women With a <i>TP53</i> Pathogenic Variant-Reference-Cited by-同舟云学术

Breast Cancer Risk for Women With a TP53 Pathogenic Variant

Published:2024-05 Issue:8 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precis Oncol

Author:

Li Shuai¹^ORCID,Hopper John L.¹^ORCID

Affiliation:

1. Shuai Li, PhD, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia, Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia; and John L. Hopper, PhD, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia

Abstract

The article highlights that breast cancer risk for women with TP53 mutations depends on family history.

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.24.00166

Reference10 articles.

1. Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction

2. Penetrance of Breast Cancer Susceptibility Genes from the eMERGE III Network

3. Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study

4. Risks of first and subsequent cancers amongTP53mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to S. Li et al;JCO Precision Oncology;2024-05